📜 Post with us on Reddit
📝 Create a new article
🏭 Create a company page
🇬🇧 - in English
🇫🇷 - en Français (FR)
🇵🇹 - em Português (PT)
🇩🇪 - in Deutsch (DE)
🇯🇵 - 日本語で (JA)
Sponsored articles

You can edit almost every page by Creating an account. Otherwise, see the FAQ.

Peyman Saadat

From EverybodyWiki Bios & Wiki


Peyman Saadat (born February 9, 1973 in Tehran), is an Iranian-American reproductive fertility physician based in Southern California.

Biography[edit]

Saadat was born and raised in Tehran, Iran, and migrated to the United States when he was 13 years old. Saadat attended Fairfax High School in Los Angeles and graduated in 1988. He then graduated from California State University, Northridge in 1992 with a Bachelor of Arts with honors in biology. Later, Saadat enrolled in the University of Southern California School of Medicine in 1992, where he spent four years studying and graduated with his medical degree in 1996.

Saadat then went on to complete his internship in 1997 and a residency in 2000 at the Los Angeles County and USC Medical Center, Department of Obstetrics and Gynecology. In 2003, he completed a fellowship at the Women’s and Children’s Hospital at USC Medical Center, Department of Obstetrics and Gynecology, Reproductive Endocrinology and Infertility division.

In 2017, Saadat made an appearance in the television show Love & Hip Hop: Hollywood episode “Make It Count.”

Personal life[edit]

Saadat currently resides in Los Angeles, California. He is married to Shohreh Saadat, and they have two children, Sharlene and Aiden Saadat.

Certifications[edit]

Professional affiliations[edit]

Department of Obstetrics/Gynecology — Cedars Sinai Medical Center[2]

Department of Obstetrics/Gynecology — Kaiser Baldwin Park Medical Center[3]

Attending Physician and Clinic Volunteer, LAC+USC Medical Center

Attending Physician, Beverly Sunset Surgical Center[4]

Associate Member, American Society for Reproductive Medicine[5]

Associate Member, Society for Reproductive Endocrinology and Infertility, Inc.[6]

Associate Member, American College of Obstetrics/Gynecology

Associate Member, Pacific Coast Fertility Society

Controversy[edit]

In 2016, Saadat and his practice were accused of misplacing a woman’s deceased husband’s sperm.[7] The woman sued Saadat,[8] and the case is still pending.[9]

Published works[edit]

Saadat has been featured in various peer-review journals, non peer-review journals, and textbooks pertaining to his specialty in fertility studies.

  • Slattery WH III, Saadat P. Postinflammatory medial canal fibrosis. Am J Otol 1997;18:294-7.[10]
  • Berkowitz K, Reyes C, Saadat P, Kjos SL. Fetal lung maturation: Comparison of biochemical indices in gestational diabetic and nondiabetic pregnancies. J Reprod Med 1997;42:793–800.[11]
  • Mor E, Saadat P, Sokol RZ, Paulson RJ. Spontaneous twin gestation after vaginal dilation in a woman with uterus didelphys and bladder exstrophy. Obstet Gynecol 2002;100:1138–41.[12]
  • Paulson RJ, Boostanfar R, Saadat P, Mor E, Tourgeman DE, Slater CC, Francis MM, Jain JK. Pregnancy in the sixth decade of life: Obstetrical outcomes in women of advanced reproductive age. JAMA 2002;288:2320-3.[13]
  • Saadat P, Slater CC, Jain JK, Tourgeman DE, Stanczyk FZ, Paulson RJ. Treatment-associated serum FSH levels in very poor responders to ovarian stimulation. J Assist Reprod Genet 2003;20:395-9.[14]
  • Mor E, Zograbyan A, Saadat P, Bayrak A, Tourgeman DE, Zhang C, Stanczyk FZ, Paulson RJ. The insulin resistant subphenotype of polycystic ovary syndrome: Clinical parameters and pathogenesis. Am J Obstet Gynecol 2004;190:1654-60.[15]
  • Saadat P, Boostanfar R, Slater CC, Tourgeman DE, Stanczyk FZ, Paulson RJ. Accelerated endometrial maturation in the luteal phase of cycles utilizing controlled ovarian hyperstimulation: Impact of gonadotropin-releasing hormone agonists versus antagonists. Fertill Steril 2004;82:167-71.[16]
  • Bayrak A, Saadat P, Mor E, Chong L, Paulson RJ, Sokol RZ. Evaluation of hyperprolactinemia: When is pituitary imaging indicated? Fertil Steril, submitted.[17]
  • Saadat D, Saadat P. Bell’s Palsy and its management with steroids. USC J Med 1994;6:14-7.
  • Saadat P, Boostanfar R, Roy S. Postpartum endometritis. In: Mishell DR Jr, Goodwin TM, Brenner PF, editors, Management of Common Problems in Obstetrics and Gynecology, Fourth Edition, pp. 145–6, 2002. Blackwell Science, Inc., Malden, Massachusetts.[18]
  • Saadat P, Roy S. Sexually transmitted diseases. In: Mishell DR Jr, Goodwin TM, Brenner PF, editors, Management of Common Problems in Obstetrics and Gynecology, Fourth Edition, pp. 214–6, 2002. Blackwell Science, Inc., Malden, Massachusetts.[19]
  • Saadat P, Stek A, Roy S. Human immunodeficiency virus. In: Mishell DR Jr, Goodwin TM, Brenner PF, editors, Management of Common Problems in Obstetrics and Gynecology, Fourth Edition, pp. 217–20, 2002. Blackwell Science, Inc., Malden, Massachusetts.
  • Saadat P, Roy S. Pelvic infection. In: Mishell DR Jr, Goodwin TM, Brenner PF, editors, Management of Common Problems in Obstetrics and Gynecology, Fourth Edition, pp. 224–7, 2002. Blackwell Science, Inc., Malden, Massachusetts.[20]
  • Saadat P, Rosenberg E. The use of water soluble organometallic macromolecule for labeling nucleic acids. Presented at the Sigma Xi Research Forum, April, 1992, Northridge, California.
  • Gentzschein E, Saadat P, Cho MM, Lim A, Huang R, Paulson RJ, Stanczyk FZ. Dynamics of androgen and SHBG production during the pill-free interval in women receiving different oral contraceptive formulations. Presented at the 47th Annual Meeting of the Society for Gynecologic Investigation, March 22–25, 2000, Chicago, Illinois.
  • Saadat P, Boostanfar R, Poysky J, Buckwalter G, Saadat P, Zhang C, Guan C, Goharkhay N, Stanczyk F, Roy S. A randomized pilot study comparing the effects of hormone replacement therapy containing medroxyprogesterone acetate to micronized progesterone on mood, libido and serum endocrine markers in postmenopausal women. Presented at the 56th Annual Meeting of the Obstetrical and Gynecological Assembly of Southern California, February 1–4, 2001, Los Angeles, California.
  • Saadat P, Boostanfar R, Stanczyk FZ, Paulson RJ, Buckwalter G, Roy S. Effect of hormone replacement therapy containing medroxyprogesterone acetate or micronized progesterone on mood, libido and serum endocrine markers in postmenopausal women. Presented the 48th Annual Meeting of the Society for Gynecologic Investigation, March 14–17, 2001, Toronto, Ontario, Canada.
  • Saadat P, Lu JJ, Felix JC, Paulson RJ, Stanczyk, FZ. Androgen and estrogen levels in ovarian tissue obtained from patients with polycystic ovarian syndrome (PCOS) and granulosa cell tumors (GCT). Presented at the 48th Annual Meeting of the Society for Gynecologic Investigation, March 14–17, 2001, Toronto, Ontario, Canada.
  • Zhang C, Saadat P, Saadat P, Paulson RJ, Stanczyk FZ. Correlation of serum bioavailable testosterone levels determined by the ammonium sulfate precipitation method with corresponding calculated free and bioavailable testosterone levels. Presented at the 48th Annual Meeting of the Society for Gynecologic Investigation, March 14–17, 2001, Toronto, Ontario, Canada.
  • Saadat P, Slater CC, Patel S, Jain JK, Stanczyk FZ, Paulson RJ. Very high FSH levels do not result in additional follicular development in poor responders to ovarian stimulation. Presented at the 49th Annual Meeting of the Pacific Coast Reproductive Society, April 25–29, 2001, Rancho Mirage, California. (Fellow Award).[21]
  • Boostanfar R, Campeau JD, Saadat P, Tourgeman DE, Slater CC, Jain JK, diZerega GS, Kobak WH. Use of the Harmonic Scapelâ as a novel technique for distal neosalpingostomy. Presented at the 30th Annual Meeting of the American Association of Gynecologic Laparoscopists, November 16–19, 2001, San Francisco, California.[22]
  • Saadat P, Ji Qing, Lu J, Chang L, Paulson RJ, Stolz A, Stanczyk FZ. Expression of the 3a-HSD gene in genital skin from hirsute and non-hirsute women. Presented at the 49th Annual Meeting of the Society for Gynecologic Investigation, March 20–23, 2002, Los Angeles, California.
  • Saadat P, Mor E, Kives S, Zhang X, Paulson RJ, Stanczyk FZ, Reid RL. Alterations in circulating androgen levels following oral and vaginal administration of the Yuzpe regimen and plan B for emergency contraception. Presented at the 49th Annual Meeting of the Society for Gynecologic Investigation, March 20–23, 2002, Los Angeles, California.[23]
  • Saadat P, Poysky J, Boostanfar R, Munevar C, Buckwaler JG, Stanczyk FZ, Roy S. Cognitive functioning during hormonal replacement therapy. Presented at the 49th Annual Meeting of the Society for Gynecologic Investigation, March 20–23, 2002, Los Angeles, California.
  • Mor E, Saadat P, Kives S, Zhang X, Paulson RJ, Stanczyk FZ, Reid RL. Alterations in hepatic proteins following oral and vaginal administration of the Yuzpe regimen and plan B for emergency contraception. Presented at the 49th Annual Meeting of the Society for Gynecologic Investigation, March 20–23, 2002, Los Angeles, California.[24]
  • Uzelac P, Capurro C, Saadat P, Kacina A, Wohlmuth C, Stanczyk FZ. Effect of high doses of norethindrone acetate on hepatic proteins and conversion to ethinyl estradiol during treatment of acute abnormal uterine bleeding. Presented at the 49th Annual Meeting of the Society for Gynecologic Investigation, March 20–23, 2002, Los Angeles, California.
  • Mor E, Saadat P, Kives S, Zhang C, Paulson RJ, Reid R, Stanczyk FZ. Alterations in gonadotropin levels following oral and vaginal administration of the Yuzpe regimen and plan B for emergency contraception. Presented at the 50th Annual Meeting of the Pacific Coast Reproductive Society, April 17–21, 2002, Rancho Mirage, California.[25]
  • Saadat P, Boostanfar R, Mor E, Zhang C, Paulson RJ, Roy S, Stanczyk FZ. Effects of oral and transdermal hormone replacement therapy on serum free testosterone levels in postmenopausal women. Presented at the 50th Annual Meeting of the Pacific Coast Reproductive Society, April 17–21, 2002, Rancho Mirage, California.[26]
  • Saadat P, Mor E, Slater CC, Stanczyk FZ, Paulson RJ, Shoupe D, Hodis HN, Mack WJ. Postmenopausal oral estrogen replacement therapy and changes in blood pressure: A randomized placebo-controlled trial. Presented at the 50th Annual Meeting of the Pacific Coast Reproductive Society, April 17–21, 2002, Rancho Mirage, California.[27]
  • Boostanfar R, Slater C, Klumph S, Saadat P, Tourgeman D, Paulson RJ. Accelerated endometrial maturation in the luteal phase of cycles utilizing controlled ovarian hyperstimulation: Impact of GnRH agonist vs. antagonist. Presented at the 50th Annual Meeting of the Pacific Coast Reproductive Society, April 17–21, 2002, Rancho Mirage, California.[28]
  • Mor E, Saadat P, Zhang C, Stanczyk FZ, Slater CC, Jain J, Tourgeman D, Paulson RJ. Ovarian and adrenal androgen profiles in cycles of controlled ovarian hyperstimulation utilizing GnRH antagonists or agonists. Presented at the 50th Annual Meeting of the Pacific Coast Reproductive Society, April 17–21, 2002, Rancho Mirage, California.[29]
  • Saadat P, Boostanfar R, Poysky J, Munevar CM, Stanczyk FZ, Buckwaler G, Roy S. A randomized prospective study comparing the effects of micronized progesterone and medroxyprogesterone acetate on mood and libido. Presented at the 50th Annual Meeting of the Pacific Coast Reproductive Society, April 17–21, 2002, Rancho Mirage, California. (PCRS Menopause Award).[30]
  • Boostanfar R, Abbassi D, Tourgeman D, Saadat P, Jain JK, Mishell DR Jr, Paulson RJ. The comparative efficacy of tamoxifen and clomiphene citrate in obese and non-obese anovulatory women: A prospective randomized trial. Presented at the 50th Annual Meeting of the Pacific Coast Reproductive Society, April 17–21, 2002, Rancho Mirage, California.
  • Roy S, Boostanfar R, Saadat P, Poysky J, Stanczyk FZ, Buckwalter G. Serum endocrine markers and psychosexual mood in postmenopausal women: The difference between transdermal and oral HRT. Presented at the 10th World Congress on the Menopause, June 10–14, 2002, Berlin, Germany.[31]
  • Saadat P, Abbassi D, Boostanfar R, Tourgeman D, Jain JK, Mishell DR, Paulson RJ. The comparative efficacy of tamoxifen and clomiphene citrate in obese and non-obese anovulatory women: A prospective randomized trial. Presented at the 69th Annual Meeting of the Pacific Coast Obstetrical and Gynecological Society, October 22–27, 2002, Rancho Mirage, California.[32]
  • Saadat P, Aliabadi T, Tourgeman DE, Mor E, Slater CC, Paulson RJ. The utility of chlamydia trachomatis titer determination as a screening tool for the prediction of tubo-peritoneal disease. Presented at the 58th Annual Meeting of the American Society for Reproductive Medicine, October 12–17, 2002, Seattle, Washington.[33]
  • Saadat P, Abbassi D, Boostanfar R, Tourgeman D, Jain JK, Mishell DR, Paulson RJ. The comparative efficacy of tamoxifen and clomiphene citrate in obese and non-obese anovulatory women: A prospective randomized trial. Presented at the 58th Annual Meeting of the Obstetrical and Gynecological Assembly of Southern California, February 13–16, 2003, Universal City, California.[34]
  • Saadat P, Aliabadi T, Jain JK, Tourgeman DE, Slater CC, Paulson RJ. The utility of chlamydia trachomatis titer determination as a screening tool for the prediction of tubo-peritoneal disease. Presented at the 58th Annual Meeting of the Obstetrical and Gynecological Assembly of Southern California, February 13–16, 2003, Universal City, California.[35]
  • Saadat P, Saadat P, Zhang C, Chang L, Zafarian N, Mor E, Stanczyk FZ, Paulson RJ. Efficacy and reliability of commercially available direct chemiluminescent immunoassays and radioimmunoassays in predicting serum progesterone values: Should these assays be used in clinical practice? Presented at the 50th Annual Meeting of the Society for Gynecologic Investigation, March 26–30, 2003, Washington, DC.
  • Mor E, Saadat P, Bayrak A, Tourgeman DE, Jain JK, Francis MM, Paulson RJ. Pregnancy outcome in advanced reproductive age: A comparison between egg donation recipients and fertile women over 40 years of age. Presented at the 50th Annual Meeting of the Society for Gynecologic Investigation, March 26–30, 2003, Washington, DC.[36]
  • Chang L, Talwalker S, Saadat P, Ji Q, Paulson R, Stolz A, Stanczyk FZ. Quantification of testosterone and its 5a-reduced metabolites in genital skin. Presented at the 50th Annual Meeting of the Society for Gynecologic Investigation, March 26–30, 2003, Washington, DC.
  • Saadat P, Boostanfar R, Poysky J, Munevar CM, Stanczyk FZ, Buckwalter G, Roy S. A randomized prospective study comparing the effects of micronized progesterone and medroxyprogesterone acetate on subjective reports of physical status. Presented at the 51st Annual Meeting of Pacific Coast Reproductive Society, April 23–27, 2003, Rancho Mirage, California.[37]
  • Bayrak A, Saadat P, Mor E, Urwitz-Lane R, Chong L, Paulson RJ, Sokol RZ. Hyperprolactinemia: Guidelines for clinical assessment and pituitary imaging. Presented at the 51st Annual Meeting of Pacific Coast Reproductive Society, April 23–27, 2003, Rancho Mirage, California.[38]
  • Mor E, Saadat P, Bayrak A, Sokol RZ, Jain JK, Tourgeman DE, Paulson RJ. Insulin resistance in polycystic ovary syndrome: Impact on ovulation and common clinical and metabolic parameters. Presented at the 51st Annual Meeting of Pacific Coast Reproductive Society, April 23–27, 2003, Rancho Mirage, California.[39]
  • Zograbyan A, Mor E, Zhang C, Saadat P, Bayrak A, Sokol RZ, Jain JK, Tourgeman DE, Stanczyk FZ, Paulson RJ. Insulin resistance in polycystic ovary syndrome: Clinical implications of fasting glucose and insulin levels. Presented at the 70th Annual Meeting of the Pacific Coast Obstetrical and Gynecological Society, September 16–21, 2003, Anchorage, Alaska. (Frank Lynch Memorial Essay Award).[40]
  • Almassi M, Saadat P, Mor E, Chang L, Talwalker S, Ji Q, Paulson RJ, Stolz A, Stanczyk FZ. Idiopathic hirsutism: Is 5a-reductase the only pivotal enzyme? Presented at the 70th Annual Meeting of the Pacific Coast Obstetrical and Gynecological Society, September 16–21, 2003, Anchorage, Alaska.

Lectures[edit]

  • Basic Fertility Work Up and Evaluation, Kaiser Baldwin Park Medical Center – (2003)
  • Ovarian Hyperstimulation Syndrome, Kaiser Baldwin Park Medical Center – (2003)
  • Comprehensive REI Review for Board Preparation, LAC-USC – (2004)
  • Recurrent Pregnancy Loss, Kaiser Sunset Medical Center – (2005)
  • Male Infertility Workup and Treatment, Cedars Sinai Medical Center – (2005)
  • Male Infertility Workup and Treatment, Kaiser Baldwin Park Medical Center – (2005–2006)
  • Uterine Anomalies: Workup and Treatment, Kaiser Baldwin Park Medical Center (2007)
  • Recurrent Spontaneous Abortion Workup and Treatment, Kaiser Harbor City Medical Center – (2007)
  • Endometriosis Treatment And Workup, Kaiser Harbor City Medical Center – (2008)
  • Fertility Preservation, Kaiser Baldwin Park Medical Center – (2009)
  • Recurrent Spontaneous Abortion Workup and Treatment, Kaiser Bellflower/Downey Medical Center – (2009)
  • Basic Workup and Treatment for Infertility, Kaiser Baldwin Park Medical Center – (2010)[41]
  • Historical Aspects of Infertility, Kaiser Baldwin Park Medical Center – (2011)
  • IVF and Preimplantation Genetic Diagnosis; Pros and Cons, Kaiser Baldwin Park Medical Center – (2012)
  • Polycystic Ovarian Syndrome; Diagnosis and Treatment, Kaiser Baldwin Park Medical Center — (2013)
  • Endometriosis and Uterine Anomalies; Diagnosis and Treatment, Kaiser Baldwin Park Medical Center – (2014)

References[edit]

  1. ↑ "Verify Physician". www.abog.org. Retrieved 2019-01-30.
  2. ↑ "List of Participating and Non-Participating Physicians with Cedars-Sinai's FAP" (PDF).
  3. ↑ www.healthgrades.com https://www.healthgrades.com/physician/dr-peyman-saadat-yqv9c/comments?currentPage=1. Retrieved 2019-01-29. Missing or empty |title= (help)
  4. ↑ "BEVERLY SUNSET SURGICAL ASSOCIATES, LLC; NPI #1457785511". NPIdb.org. Retrieved 2019-01-29.
  5. ↑ Peyman Saadat (2017-07-23). "American Society for Reproductive Medicine – Infertility Research".
  6. ↑ "Peyman Saadat, M.D – Profile | Society for Reproductive Endocrinology and Infertility". www.socrei.org. Retrieved 2019-01-29.
  7. ↑ Lewin, Tamar (2016-07-21). "Sperm Banks Accused of Losing Samples and Lying About Donors". The New York Times. ISSN 0362-4331. Retrieved 2019-01-29.
  8. ↑ "WeHo Fertility Clinic Sued for Allegedly Misusing Sperm". wehoville.com. 2016-05-31.
  9. ↑ "SARAH ROBERTSON ET AL VS PEYMAN SAADAT ET AL". UniCourt. Retrieved 2019-01-29.
  10. ↑ Slattery, W. H.; Saadat, P. (May 1997). "Postinflammatory medial canal fibrosis". The American Journal of Otology. 18 (3): 294–297. ISSN 0192-9763. PMID 9149820.
  11. ↑ "Dec1997: Fetal Lung Maturation Comparison of Biochemical Indices in Gestational Diabetic and Nondiabetic Pregnancies". www.reproductivemedicine.com. Retrieved 2019-01-29.
  12. ↑ Mor, Eliran; Saadat, Peyman; Sokol, Rebecca Z.; Paulson, Richard J. (November 2002). "Spontaneous twin gestation after vaginal dilation in a woman with uterus didelphys and bladder exstrophy". Obstetrics and Gynecology. 100 (5 Pt 2): 1138–1141. ISSN 0029-7844. PMID 12423836.
  13. ↑ Paulson, Richard J.; Boostanfar, Robert; Saadat, Peyman; Mor, Eliran; Tourgeman, David E.; Slater, Cristin C.; Francis, Mary M.; Jain, John K. (2002-11-13). "Pregnancy in the sixth decade of life: obstetric outcomes in women of advanced reproductive age". JAMA. 288 (18): 2320–2323. doi:10.1001/jama.288.18.2320. ISSN 0098-7484. PMID 12425710.
  14. ↑ Saadat, P.; Slater, C. C.; Jain, J. K.; Tourgeman, D. E.; Stanczyk, F. Z.; Paulson, R. J. (2003). "Treatment-Associated Serum FSH Levels in Very Poor Responders to Ovarian Stimulation". Journal of Assisted Reproduction and Genetics. 20 (10): 395–399. doi:10.1023/A:1026280508821. PMC 3455170. PMID 14649378.
  15. ↑ Mor, Eliran; Zograbyan, Arus; Saadat, Peyman; Bayrak, Aykut; Tourgeman, David E.; Zhang, Chunying; Stanczyk, Frank Z.; Paulson, Richard J. (June 2004). "The insulin resistant subphenotype of polycystic ovary syndrome: clinical parameters and pathogenesis". American Journal of Obstetrics and Gynecology. 190 (6): 1654–1660. doi:10.1016/j.ajog.2004.02.052. ISSN 0002-9378. PMID 15284763.
  16. ↑ Saadat, Peyman; Boostanfar, Robert; Slater, Cristin C.; Tourgeman, David E.; Stanczyk, Frank Z.; Paulson, Richard J. (July 2004). "Accelerated endometrial maturation in the luteal phase of cycles utilizing controlled ovarian hyperstimulation: impact of gonadotropin-releasing hormone agonists versus antagonists". Fertility and Sterility. 82 (1): 167–171. doi:10.1016/j.fertnstert.2003.11.050. ISSN 0015-0282. PMID 15237007.
  17. ↑ Bayrak, Aykut; Saadat, Peyman; Mor, Eliran; Chong, Lisa; Paulson, Richard J.; Sokol, Rebecca Z. (July 2005). "Pituitary imaging is indicated for the evaluation of hyperprolactinemia". Fertility and Sterility. 84 (1): 181–185. doi:10.1016/j.fertnstert.2005.01.102. ISSN 1556-5653. PMID 16009175.
  18. ↑ Noble, Barnes &. "Management of Common Problems in Obstetrics and Gynecology / Edition 4". Barnes & Noble. Retrieved 2019-01-30.
  19. ↑ Goodwin, T. Murphy; Montoro, Martin N.; Muderspach, Laila; Paulson, Richard; Roy, Subir (2010-12-23). Management of Common Problems in Obstetrics and Gynecology. John Wiley & Sons. ISBN 9781444390346. Search this book on
  20. ↑ "Management of Common Problems in Obstetrics and Gynecology" (PDF).
  21. ↑ "Very High FSH Levels Do Not Result in Additional Follicular Development in Poor Responders to Ovarian Stimulation". www.academia.edu. Retrieved 2019-01-30.
  22. ↑ "The harmonic scalpel for distal neosalpingostomy". www.academia.edu. Retrieved 2019-01-30.
  23. ↑ Stanczyk, Frank Z.; Paulson, Richard J.; Reid, Robert L.; White, Emily; Kives, Sari; Saadat, Peyman; Mor, Eliran (2005-07-01). "Comparison of vaginal and oral administration of emergency contraception". Fertility and Sterility. 84 (1): 40–45. doi:10.1016/j.fertnstert.2005.01.110. ISSN 0015-0282. PMID 16009155.
  24. ↑ Mor, E. (2002). "Alterations in gonadotropin levels following oral and vaginal administration of the Yuzpe regimen and plan B for emergency contraception". Fertility and Sterility. 77: S6–S7. doi:10.1016/S0015-0282(02)03012-1. ISSN 0015-0282.
  25. ↑ Stanczyk, Frank Z.; Paulson, Richard J.; Reid, Robert L.; White, Emily; Kives, Sari; Saadat, Peyman; Mor, Eliran (2005-07-01). "Comparison of vaginal and oral administration of emergency contraception". Fertility and Sterility. 84 (1): 40–45. doi:10.1016/j.fertnstert.2005.01.110. ISSN 0015-0282. PMID 16009155.
  26. ↑ Saadat, P. (2002). "Effects of oral and transdermal hormone replacement therapy on serum free testosterone levels in postmenopausal women". Fertility and Sterility. 77: S7–S8. doi:10.1016/S0015-0282(02)03015-7. ISSN 0015-0282.
  27. ↑ Saadat, P. (2002). "Postmenopausal oral estrogen replacement therapy and changes in blood pressure: a randomized placebo-controlled trial". Fertility and Sterility. 77: S8. doi:10.1016/S0015-0282(02)03016-9. ISSN 0015-0282.
  28. ↑ "PCRS Abstracts".
  29. ↑ Mor, E. (2002). "Ovarian and adrenal androgen profiles in cycles of controlled ovarian hyperstimulation utilizing GnRH antagonists or agonists". Fertility and Sterility. 77: S10–S11. doi:10.1016/S0015-0282(02)03023-6. ISSN 0015-0282.
  30. ↑ [https://www.fertstert.org/article/S0015-0282(02)03053-4/pdf "FERTILITY & STERILITY�"]. replacement character in |title= at position 22 (help)
  31. ↑ "Fertility & Sterility".
  32. ↑ Paulson, R. J.; Mishell, D. R.; Jain, J. K.; Saadat, P.; Tourgeman, D.; Abbassi, D.; Boonstanfar, R. (2002-04-01). "The comparative efficacy of tamoxifen and clomiphene citrate in obese and non-obese anovulatory women: a prospective randomized trial". Fertility and Sterility. 77: S20–S21. doi:10.1016/S0015-0282(02)03052-2. ISSN 0015-0282.
  33. ↑ Paulson, Richard J.; Slater, Cristin C.; Mor, Eliran; Tourgeman, David E.; Aliabadi, Thais; Saadat, Peyman (2002-09-01). "The utility of chlamydia trachomatis titer determination as a screening tool for the prediction of tubo-peritoneal disease". Fertility and Sterility. 78: S66. doi:10.1016/S0015-0282(02)03552-5. ISSN 0015-0282.
  34. ↑ "PCRS Abstracts".
  35. ↑ "The utility of chlamydia trachomatis titer determination as a screening tool for the prediction of tuboperitoneal disease". www.academia.edu. Retrieved 2019-01-30.
  36. ↑ Paulson, Richard J.; Slater, Cristin C.; Tourgeman, David E.; Saadat, Peyman; Boostanfar, Robert; Mor, Eliran (2002-09-01). "Pregnancy outcome at the upper extreme of reproductive age: a comparison of two recipient groups". Fertility and Sterility. 78: S51–S52. doi:10.1016/S0015-0282(02)03426-X. ISSN 0015-0282.
  37. ↑ Saadat, Peyman. "A randomized prospective study comparing the effects of micronized progesterone and medroxyprogesterone acetate on subjective reports of physical status". Fertility and Sterility.
  38. ↑ "Abstracts".
  39. ↑ Saadat, Peyman. "Insulin resistance in polycystic ovary syndrome: impact on ovulation and common clinical and metabolic parameters". Fertility and Sterility.
  40. ↑ "The insulin resistant subphenotype of polycystic ovary syndrome: Clinical parameters and pathogenesis" (PDF).
  41. ↑ Wang, Erica T.; Ozimek, John A.; Greene, Naomi; Ramos, Lauren; Vyas, Nina; Kilpatrick, Sarah J.; Pisarska, Margareta D. (August 2016). "The Impact of Fertility Treatment on Severe Maternal Morbidity". Fertility and Sterility. 106 (2): 423–426. doi:10.1016/j.fertnstert.2016.03.039. ISSN 0015-0282. PMC 4975660. PMID 27063600.

External links[edit]


This article "Peyman Saadat" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Peyman Saadat. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.


Retrieved from "https://en.everybodywiki.com/index.php?title=Peyman_Saadat&oldid=944070"
License CC BY-SA 3.0
Powered by MediaWiki
Powered by Semantic MediaWiki